Relates to the classification of the drug xylazine as a controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 2 Sponsors

Jan 7, 2026 · Senate

REFERRED TO HEALTH

Jan 16, 2025 · Senate

REFERRED TO HEALTH

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 5%, measured from NY's completed sessions
Momentum -5 27/100 from the pace of recorded action
Time since last action -22 282 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.